white patients; Black patients have fewer side effects ANN ARBOR, Michigan — Clinical trials testing cancer immunotherapies significantly under-represented Black patients. So while these ...

Clinical trials testing cancer ... patients receiving immune checkpoint inhibitors through the Veteran Health Administration in 2020–2023. The cohort was comprised of 81% white patients and 19% ...

For the study, the researchers analyzed 18 studies published between 2009 and 2022 that included 34,262 Black patients and 182,466 White patients with stage I to IV breast cancer. They found that ...